Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDA

NCT05023070 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Cannabidiol
DRUG: Cannabidiol
DRUG: Cannabidiol
DRUG: Cannabidiol

Sponsor

Icahn School of Medicine at Mount Sinai